Pharmafile Logo
Pharmafocus logo
Advanced Search

influenza

Showing 15 posts of 43 posts found.

screen_shot_2019-01-29_at_15

Beating the flu

February 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flu, influenza, pharma, seqirus

On 14 January, the European Commission issued marketing approval for Flucelvax Tetra, the first cell-based, quadrivalent influenza vaccine. Pharmafocus spoke …

Feature
3-dimensional-model-of-influenza-virus-3d-graphical-representation-of-influenza-virion-ultrastructure-562x544

Seqirus secures first cell-based quadrivalent influenza vaccine approval in Europe

January 14, 2019
Sales and Marketing Europe, Flucelvax, flu, influenza, pharma, seqirus

Seqirus has made it known that its new cell-based seasonal influenza vaccine Flucelvax Tetra has been approved by the European …

News

Vaccine coverage falls by 6.2% since last year

October 29, 2018
Sales and Marketing CDC, flu, influenza, vaccine coverage, vaccines

Despite the severity of the flu season, just 37.1% of American adults received the flu vaccine this year, according to …

News
flu

First novel, single-dose flu drug approved in US in almost 20 years

October 25, 2018
Sales and Marketing FDA, Shionogi, Xofluza, flu, influenza, pharma

The FDA has announced that it has approved the first single-dose flu drug with a novel mechanism of action in …

News
injection

More effective flu vaccine could prevent hundreds of elderly deaths across UK this winter

September 12, 2018
Medical Communications, Research and Development NHS, Vaccine, flu, influenza, pharma

Public Health England has revealed that an enhanced, “adjuvanted” vaccine is to be made available for over-65s this winter, and …

News

Pfizer partners up with BioNTech for $425m to pursue mRNA flu vaccines

August 16, 2018
Research and Development BioNTech, Pfizer, Vaccine, flu, influenza, pharma

Pfizer has announced a partnership with German biotech firm BioNTech after signing a multi-year deal worth $425 million to develop …

News

Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?

July 17, 2018
Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma

Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …

News
pills-384846_960_720

World’s first synthetic, non-biologic vaccine developed

March 14, 2018
Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …

News
flumist

CDC U-turns previous decision on AZ’s flu vaccine

February 22, 2018
Sales and Marketing AstraZeneca, Vaccine, biotech, drugs, flu, influenza, pharma, pharmaceutical

The US Centers for Disease Control and Prevention (CDC) has now recommended AstraZeneca’s FluMist as an option for doctors for …

News
flu_virus

Low flu vaccine efficacy may be due to previous immune history, study finds

February 20, 2018
Manufacturing and Production, Research and Development H3N2, Vaccine, flu, flue vaccine, influenza, pharma

The sometimes poor efficacy of influenza vaccines may be due to poor immune response and a patient’s wider immune history, …

News

Bill & Melinda Gates Foundation shows faith in CureVac

February 14, 2018
Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …

News
flu

New flu med can destroy influenza virus in one day

February 13, 2018
Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical

Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate

As we come to the end of January, it’s Friday again – time for another rundown of the top ten …

News
influenza_dan_higgins_douglas_jordan_uscdcp

New vaccine provides universal protection against influenza A, study finds

January 24, 2018
Research and Development Georgia State University, Vaccine, flu, influenza, pharma

Research led by Georgia State University has enabled the development of a universal vaccine for influenza A viruses, proven to …

News
seqirus_08-11-17_full-42_003_web

Seqirus announces £40m UK fill-and-finish flu vaccine facility

November 9, 2017
Manufacturing and Production Liverppol, Novartis, UK, Vaccine, flu, influenza, pharma, seqirus

Seqirus, an influenza vaccine specialist subsidiary of global biotech firm CSL, has announced a £40 million investment into a new …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026